Bridging the gaps between Radiology, Urology & Oncology, Eigen improves healthcare and quality of life through innovative breakthroughs in image-guided disease diagnosis and treatment. Our ingenuity and foresight, coupled with our ongoing involvement with the scientific and medical communities, positions us at the vanguard of emerging technology used for detecting, localizing and managing prostate cancer. Eigen holds numerous patents in its growing intellectual property portfolio.

Eigen adheres to the highest standard in medical device regulatory compliance. We place great importance on effective risk management, as well as the best practices specific to safe medical device design, manufacture and installation. Demonstrating overall industry excellence, ISO 13485 certification aligns Eigen with international regulatory requirements and permits us to pursue sales and distribution in Canada, EU countries, other European countries, Latin America, Iran, Turkey, China, HK, Philippines, Korea, Turkey, India, Mexico in addition to our leading role throughout the USA.


Health Care

Health Diagnostics

Medical Devices

Eigen

Mahtab Damda

Dr Michael A.

Jennifer Pebe

Gary Carter

Shambhu Acharya

The Research and Development team at Eigen focuses on pioneering advancements in image-guided technologies for prostate cancer diagnosis and treatment. Collaborating closely, team members leverage their expertise in engineering and cryogenics to develop innovative medical devices and software solutions, ensuring compliance with regulatory standards and enhancing patient care. Through rigorous research and collaboration with medical professionals, the team drives the company’s commitment to improving healthcare outcomes.

Research and Development

Engineering Team

Leadership Team

Research and Development

About

Team members

Other teams at Eigen

Engineering Team

Leadership Team